ImmunityBio (IBRX) Exchange Rate Effect (2020 - 2026)
ImmunityBio (IBRX) posted quarterly Exchange Rate Effect of $122000.0 for Q1 2026, up 1320.0% year-over-year from $8591.5 in Q1 2025, and up 2340.0% quarter-over-quarter from $5000.0 in Q4 2025.
Powered by 
Analysis
ImmunityBio (IBRX) Exchange Rate Effect (2020 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Exchange Rate Effect for 7 consecutive years, with $122000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 1320.0% year-over-year to $122000.0; the TTM figure through Mar 2026 stood at $147000.0 (up 2350.0% YoY), while the FY2025 annual figure was $15000.0, up 165.22% from the prior year.
- Exchange Rate Effect climbed to $122000.0 in Q1 2026 per IBRX's latest filing, from $5000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $255000.0 in Q2 2022 and bottomed at -$254000.0 in Q1 2023.
- Historically, Exchange Rate Effect has averaged $6235.3 across 5 years, with a median of -$1000.0 in 2023.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect plunged 609.09% — and 2026, when it soared 1320.0%.
- ImmunityBio's Exchange Rate Effect stood at $161000.0 in 2022, then sank by 116.77% to -$27000.0 in 2023, then soared by 74.07% to -$7000.0 in 2024, then surged by 171.43% to $5000.0 in 2025, then soared by 2340.0% to $122000.0 in 2026.
- Business Quant data shows IBRX's Exchange Rate Effect at $122000.0 in Q1 2026, $5000.0 in Q4 2025, and -$56000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | ImmunityBio | 8.51 Bn | 8.15 Bn | 50.94 Mn | -3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Jun 30, 2025 | 76,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | -254,000.00 |
| Dec 31, 2022 | 161,000.00 |
| Sep 30, 2022 | 43,000.00 |
| Jun 30, 2022 | 255,000.00 |
| Mar 31, 2022 | -175,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 44,000.00 |